Licensee identified 7 leaking
Iodine-125 leftover prostate seeds from two patient doses: 3/11/08, 4 seeds. 3/12/08, 3 seeds. Patients were recalled, but showed no
iodine uptake. Licensee phoned [state radiation protection officials].
Seeds are approximately 0.3 micro Curies each.
Mills Pharmaceuticals (Core oncology-Oklahoma City) manufactures the seed sources. They are then sent to Medtech Diagnostic Services, Ft Meyers, Florida. Medtech loads the seeds into cartridges and sterilizes order. Medtech then sends the loaded cartridges to Carolinas Medical Center.
The state, licensee, and manufacturer are working together to determine where the seeds got damaged, whether at manufacturing, loading, or unloading.
Incident Number 08-12.
- * * UPDATE FROM GERALD SPATE TO JOE O'HARA AT 1055 ON 3/20/08 * * *
The state called to correct an editorial error on the original report. The seed activity is 0.36 milli Curies vice 0.3 micro Curies.
Notified R1DO(Perry) and
FSME(Burgess).